Literature DB >> 17561948

Chronic high-frequency deep brain stimulation of the STN/SNr for progressive myoclonic epilepsy.

Jan Vesper1, Bernhard Steinhoff, Sabine Rona, Christian Wille, Sonja Bilic, Guido Nikkhah, Christoph Ostertag.   

Abstract

Chronic high-frequency deep brain stimulation (DBS) may also be effective in patients with refractory epilepsy. A possible benefit has been postulated because of the connections that exist between the subthalamic nucleus (STN) and the superior colliculus. Individual case reports and pilot studies of successful DBS in different types of epilepsy have already been presented. Here, the case of a 39-year-old male with progressive myoclonic epilepsy is reported who remained severely impaired despite VNS and combined antiepileptic drug therapy. Bilateral DBS electrodes were implanted into the STN, followed by implantation of a neurostimulation system under general anesthesia. Adjustment and testing of the remaining contacts was done over several months postoperatively. Bilateral monopolar DBS reduced the intensity and frequency of seizures by 50%. The patient has so far been followed for 12 months. This is the first report of positive effects of DBS in progressive myoclonic epilepsy in an adult patient. A subsequent prospective study will have to investigate whether the STN or other target nuclei are most suitable for DBS in these types of epilepsy and which long-term results can be obtained.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17561948     DOI: 10.1111/j.1528-1167.2007.01166.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  18 in total

1.  Treating epilepsy via adaptive neurostimulation: a reinforcement learning approach.

Authors:  Joelle Pineau; Arthur Guez; Robert Vincent; Gabriella Panuccio; Massimo Avoli
Journal:  Int J Neural Syst       Date:  2009-08       Impact factor: 5.866

Review 2.  Deep brain stimulation for the treatment of epilepsy: circuits, targets, and trials.

Authors:  Nealen G Laxpati; Willard S Kasoff; Robert E Gross
Journal:  Neurotherapeutics       Date:  2014-07       Impact factor: 7.620

Review 3.  Drug Treatment of Progressive Myoclonic Epilepsy.

Authors:  Gregory L Holmes
Journal:  Paediatr Drugs       Date:  2020-04       Impact factor: 3.022

4.  Modeling noninvasive neurostimulation in epilepsy as stochastic interference in brain networks.

Authors:  Catherine Stamoulis; Bernard S Chang
Journal:  IEEE Trans Neural Syst Rehabil Eng       Date:  2012-06-04       Impact factor: 3.802

Review 5.  Physiology-Based Treatment of Myoclonus.

Authors:  Ashley B Pena; John N Caviness
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620

Review 6.  Seizure outcomes in nonresective epilepsy surgery: an update.

Authors:  Dario J Englot; Harjus Birk; Edward F Chang
Journal:  Neurosurg Rev       Date:  2016-05-21       Impact factor: 3.042

Review 7.  Emerging treatments for progressive myoclonus epilepsies.

Authors:  Antonella Riva; Alberto Guglielmo; Ganna Balagura; Francesca Marchese; Elisabetta Amadori; Michele Iacomino; Berge Arakel Minassian; Federico Zara; Pasquale Striano
Journal:  Expert Rev Neurother       Date:  2020-03-17       Impact factor: 4.618

Review 8.  The role of the basal ganglia in the control of seizure.

Authors:  J Vuong; Annaelle Devergnas
Journal:  J Neural Transm (Vienna)       Date:  2017-08-01       Impact factor: 3.575

9.  Surgical treatment for refractory epilepsy: review of patient evaluation and surgical options.

Authors:  Kristen M Kelly; Steve S Chung
Journal:  Epilepsy Res Treat       Date:  2011-06-05

10.  Deep brain stimulation for refractory epilepsy.

Authors:  Tomasz Tykocki; Tomasz Mandat; Anna Kornakiewicz; Henryk Koziara; Paweł Nauman
Journal:  Arch Med Sci       Date:  2012-10-08       Impact factor: 3.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.